Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Anesth Analg. 2019 Feb;128(2):288–295. doi: 10.1213/ANE.0000000000002794

Table 3.

Primary and Secondary Outcomes in the Propensity-Matched Cohort With Platelet Counts ≤ 50 × 109/L

No Platelet Transfusion
(N=229)
Platelet Transfusion
(N=229)
Outcome Event (%) Event (%) OR (95% CI) p-value
 RBC transfusion within 24 hours 29 (12.7%) 106 (46.3%) 5.9 (3.7, 9.5) <0.001
 ICU mortality 40 (17.5%) 41 (17.9%) 1.0 (0.6, 1.7) 0.903
 All-cause 30-day mortality 75 (32.8%) 81 (35.4%) 1.1 (0.8, 1.7) 0.554

Outcome Mean (SD) Mean (SD) Mean Rate Ratio (95% CI) p-value
 ICU-free days 19.9 (10.5) 18.3 (10.6) 0.9 (0.8, 1.1) 0.399
 Hospital-free days 10.2 (10.0) 7.8 (9.4) 0.8 (0.5, 1.1) 0.144

Outcome Mean (SD) Mean (SD) Mean Difference (95% CI)§ p-value§
 Change in SOFA score* −0.3 (2.9) −0.5 (3.5) −0.2 (−0.8, 0.4) 0.553

CI – confidence interval, ICU – intensive care unit, RBC – red blood cell, SOFA – sequential organ failure assessment, SD – standard deviation.

Estimate and p-value comes from logistic regression. An odds ratio > 1 implies increased odds for the outcome in those receiving platelet transfusions.

Estimate and p-value comes from negative binomial regression. A rate ratio < 1 implies decreased mean for the outcome in those receiving platelet transfusions. Specifically, a rate ratio of 0.9 can be interpreted as a 10% decrease in the mean for those receiving platelet transfusions compared to those who did not.

*

Change in SOFA score defined as 24-hr SOFA score – Baseline SOFA score, with negative values reflecting improvement in SOFA scores in the ensuing 24 hours.

§

Estimate and p-value comes from linear regression. A mean difference > 0 implies less improvement in SOFA score in those receiving platelet transfusions